Extended list of
our Products
"The best way to predict the future is to create it"
Abraham Lincoln
this is what we do

Our mission in PharOS is to materialize in the most efficient way our customers trust, by ensuring that their products will be among the first to be launched after patent expiry and the last ones to exit the market.

the first to be launched after patent expiry and the last ones to exit the market.

ACTIVE INGREDIENT
THERAPEUTIC CATEGORY
DELIVERY FORM
STRENGTH(S)
PREVIEW
SILODOSIN
Urological
Hard Capsules
4mg, 8mg
SILODOSIN
ENLARGE
DRONEDARONE
CVS
FILM COATED TABLET
400mg
DRONEDARONE
ENLARGE
TICAGRELOR
Antithrombotic
FILM COATED TABLET
60mg, 90mg
TICAGRELOR
ENLARGE
NICOTINE
Nicotine Depedence
Oromucosal Spray
1mg/spray
NICOTINE
ENLARGE
APREPITANT
Antiemetics/Antinauseants
Hard Capsules
80mg, 125mg
APREPITANT
ENLARGE
GEFITINIB
Oncology
FILM COATED TABLET
250mg
GEFITINIB
ENLARGE
ATAZANAVIR
Antivirals
Hard Capsules
100mg, 150mg, 200mg, 300mg
ATAZANAVIR
ENLARGE
* Availability of products is subject to patent restrictions in countries where applicable patents are in effect. Exclusivity restrictions may apply.
CONTACT
businessdevelopment
@pharosgr.gr
For our current
product pipeline